Does Broadcom's Recent Lackluster Quarterly Results Show a Crack in the AI Trade? Not Necessarily, But It's an Important Lesson for Investors

Broadcom's fiscal Q2 2026 results were strong, with revenue up 48% year over year and diluted EPS up 85%, but both revenue and AI data center guidance came in slightly below Wall Street estimates. The miss sparked a sell-off in Broadcom and a broader rotation out of large-cap tech and AI into banks and healthcare. Despite the pullback, Broadcom remains a $1.83 trillion company and is still up 59% over the past year.

Analysis

The market’s reaction says less about Broadcom’s quarter than about positioning. When a large, high-multiple AI bellwether misses by a modest amount, the marginal seller is usually not fundamental — it’s crowded ownership de-risking a factor book. That makes the signal more important for index behavior than for AVGO’s intrinsic value: the first-order move is multiple compression, while the second-order effect is a temporary bid for cash-generative defensives and software/semis with less consensus ownership.

Competitive dynamics likely shift at the margin toward the broader AI supply chain, not away from AI itself. If hyperscalers diversify custom silicon sources, the real beneficiaries are adjacent infrastructure names that monetize capex regardless of whose chip wins the socket: foundry, packaging, networking, and memory chain vendors. Conversely, any evidence that a single customer is optimizing for supplier redundancy is a warning that custom silicon economics may become less concentrated, which would cap AVGO’s terminal multiple even if revenue keeps compounding.

The contrarian read is that the selloff may be over-extended relative to the underlying business durability. A slight guide miss after a huge run often resets expectations by one to two quarters, not one to two years; if AI capex remains above trend, the stock can recover quickly once revisions stabilize. The real risk window is 1-3 months: if another mega-cap AI name prints a similar “good-not-great” outcome, the factor rotation could broaden into a more sustained de-grossing of the AI complex.

Key Decisions for Investors

• Trim AVGO into strength over the next 1-2 weeks rather than selling into panic; the better risk/reward is to reduce size on any relief rally, since the catalyst is valuation reset rather than a broken fundamental.
• Relative-value: long NVDA / short AVGO for 1-3 months if you want AI exposure with lower single-customer concentration risk; NVDA should hold up better if the market rewards breadth of demand over custom-chip execution.
• Use a basket hedge: short QQQ against a long book of defensives/healthcare for 4-8 weeks; this captures the likely second-order rotation if AI leadership remains fragile.
• Add to GOOGL on weakness over the next month if the market keeps pricing in supplier diversification; Alphabet retains strategic control over AI capex and can absorb incremental custom-silicon redundancy without impairing near-term spend.
• For hedged accounts, buy 1-2 month AVGO put spreads rather than outright puts; implied vol is likely elevated after the move, so spreads preserve convexity while limiting theta bleed.